Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Victor Hoffbrand

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Clinical Advances in Hematology & Oncology : H&O|September 17, 2005
Oral iron chelators in the treatment of hematologic diseasesA Victor Hoffbrand
Best Practice & Research. Clinical Haematology|March 2, 2005
Deferiprone therapy for transfusional iron overloadA Victor Hoffbrand
British Journal of Haematology|November 15, 2013
Professor John Scott, folate and neural tube defectsA Victor Hoffbrand
Best Practice & Research. Clinical Haematology|May 4, 2002
Molecular analysis of minimal residual disease in adult acute lymphoblastic leukaemiaLetizia Foroni, A Victor Hoffbrand
The New England Journal of Medicine|November 29, 2018
The Role of Deferiprone in Iron ChelationRobert C Hider, A Victor Hoffbrand
The New England Journal of Medicine|February 28, 2019
The Role of Deferiprone in Iron Chelation. ReplyRobert C Hider, A Victor Hoffbrand
Lancet (London, England)|November 28, 2021
Mandatory UK folic acid fortificationNicholas J Wald, A Victor Hoffbrand
Leukemia Research|August 26, 2006
Is "leukemia" an appropriate label for all patients who meet the diagnostic criteria of chronic lymphocytic leukemia?A Victor Hoffbrand, Terry J Hamblin
Blood|March 15, 2003
Role of deferiprone in chelation therapy for transfusional iron overloadA Victor Hoffbrand, Alan Cohen, Chaim Hershko
The American Journal of Clinical Nutrition|December 9, 2004
Folic acid fortification in the prevention of neural tube defectsNicholas J Wald, Malcolm Law, A Victor Hoffbrand
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Clinical Advances in Hematology & Oncology : H&O|September 17, 2005
Oral iron chelators in the treatment of hematologic diseasesA Victor Hoffbrand
Best Practice & Research. Clinical Haematology|March 2, 2005
Deferiprone therapy for transfusional iron overloadA Victor Hoffbrand
British Journal of Haematology|November 15, 2013
Professor John Scott, folate and neural tube defectsA Victor Hoffbrand
Best Practice & Research. Clinical Haematology|May 4, 2002
Molecular analysis of minimal residual disease in adult acute lymphoblastic leukaemiaLetizia Foroni, A Victor Hoffbrand
The New England Journal of Medicine|November 29, 2018
The Role of Deferiprone in Iron ChelationRobert C Hider, A Victor Hoffbrand
The New England Journal of Medicine|February 28, 2019
The Role of Deferiprone in Iron Chelation. ReplyRobert C Hider, A Victor Hoffbrand
Lancet (London, England)|November 28, 2021
Mandatory UK folic acid fortificationNicholas J Wald, A Victor Hoffbrand
Leukemia Research|August 26, 2006
Is "leukemia" an appropriate label for all patients who meet the diagnostic criteria of chronic lymphocytic leukemia?A Victor Hoffbrand, Terry J Hamblin
Blood|March 15, 2003
Role of deferiprone in chelation therapy for transfusional iron overloadA Victor Hoffbrand, Alan Cohen, Chaim Hershko
The American Journal of Clinical Nutrition|December 9, 2004
Folic acid fortification in the prevention of neural tube defectsNicholas J Wald, Malcolm Law, A Victor Hoffbrand
Pageof 4